Stock Price Quote

SEQUENT SCIENTIFIC LTD.

NSE : SEQUENTBSE : 512529ISIN CODE : INE807F01027Industry : Pharmaceuticals & DrugsHouse : Sequent
BSE84.300.3 (+0.36 %)
PREV CLOSE ( ) 84.00
OPEN PRICE ( ) 84.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14724
TODAY'S LOW / HIGH ( )83.75 84.70
52 WK LOW / HIGH ( )52 99.35
NSE84.400.4 (+0.48 %)
PREV CLOSE( ) 84.00
OPEN PRICE ( ) 84.45
BID PRICE (QTY) 84.40 (1000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4566633
TODAY'S LOW / HIGH( ) 83.60 84.70
52 WK LOW / HIGH ( )51.7 99.25
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1985
Management Info
Gopakumar G Nair - Chairman Manish Gupta - Managing Director
Registered Office

Address 301, 'dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate, Thane (W) ,
Thane,
Maharashtra-400604

Phone

Email pidsecretarial@yahoo.co.in

Website http://www.sequent.in/

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

09May Carlyle Group enters into binding agre
The Carlyle Group and CA Harbor Investments, an affiliated entity of CAP..
08Apr Sequent Scientific informs about press
Sequent Scientific has informed that the company hasenclosed a copy of P..
12Mar Sequent Scientific gets WHO - GENEVA’s
Sequent Scientific, which has businesses across Animal Health (Alivira)..
12Mar Announcement under Regulation 30 (LOD
We enclose herewith a copy of Press Release that is issued by the Compan..
05Feb Sequent Scientific informs about discl
Sequent Scientific has informed that the exchange has received disclosur..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit29.190000000000175.86
Gross Profit 46.9300000000001 62.03
Operating Profit 80.7800000000001166.87
Net Sales 617.991676.77

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Aarti Drugs (BSE)
peergroup  939.50 (6.77%)
M.Cap ( in Cr)2189.04
Valiant Organics (BSE)
peergroup  1329.00 (3.22%)
M.Cap ( in Cr)1614.63
Ajanta Pharma (BSE)
peergroup  1485.20 (2.72%)
M.Cap ( in Cr)12960.04
Procter&Gamble Healt (BSE)
peergroup  4079.65 (0.97%)
M.Cap ( in Cr)6771.97
Alembic Pharma (BSE)
peergroup  860.75 (3.03%)
M.Cap ( in Cr)16226.51

Shareholding Pattern

PROMOTERS 56.15%
NON-INSTITUTION 32.88%
MUTUAL FUNDS/UTI 3.79%
FI/BANKS/INSURANCE 0.42%
GOVERNMENT 0%
FII 0%

About Sequent Scientific Ltd.

Sequent Scientific Ltd. was incorporated in the year 1985. Its today's share price is 84. Its current market capitalisation stands at Rs 2093.77 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10393.07 Cr and Total Income of Rs.10479.79 Cr. The company's management includes K E C Raja Kumar, S Devendra, Narendra Mairpady, Kausalya Santhanam, Sharat Narasapur, Manish Gupta, Gopakumar G Nair.

It is listed on the BSE with a BSE Code of 512529 , NSE with an NSE Symbol of SEQUENT and ISIN of INE807F01027. It's Registered office is at 301, 'dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate, Thane (W) Thane-400604, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X